bioRxiv / medRxiv
open access
OPA1 controls mitochondrial dysfunction-driven liver fibrosis in MASLD
Progressive hepatic fibrosis is the principal determinant of morbidity and mortality in metabolic dysfunction-associated steatotic liver disease and steatohepatitis (MASLD/MASH). Mitochondrial dysfunction is a hallmark of MASH, and the release of mitochondrial damage-associated molecular patterns (m
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Neurometabolic Profile of Individuals With Primary Mitochondrial Disease#1410030
- Flavonoids in MASLD: preclinical mechanisms, pharmacological targets, and translational challenges.#439111
- Lipoprotein and Apolipoproteins With Metabolic Liver Diseases#873696
- The Development of MASLD Among Survivors of Breast or Colorectal Cancer#343833
- O2 Transport and Utilization in Health and Lung Disease#1152468
Record · ID 1450935
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive